REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Maple Cross Remedies Private Limited (India)

Main Activities: Other Ambulatory Health Care Services
Full name: Maple Cross Remedies Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Maple Cross Remedies Private Limited is an unlisted company, incorporated on 12/06/2001. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U85199MH2001PTC132312 and registration number is 132312. The company is a trade company, it is engaged in wholesale trading.

Legal Address
F-714 Autumn Grove Chs Ltd., Akurli Road, Near Lokhandwala Foundation School, Kandivali (E)
Mumbai; Maharashtra; Postal Code: 400101

Contact Details: Purchase the Maple Cross Remedies Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Maple Cross Remedies Private Limited report to view the information.
Registered Capital:
Purchase the Maple Cross Remedies Private Limited report to view the information.
Incorporation Date:
June 12, 2001
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Maple Cross Remedies Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
0.16%▲
Total operating revenue
-0.05%▼
Operating profit (EBIT)
3.98%▲
EBITDA
12.16%▲
Net Profit (Loss) for the Period
4.54%▲
Total assets
-0.18%▼
Total equity
17.62%▲
Operating Profit Margin (ROS)
0.1%▲
Net Profit Margin
0.08%▲
Return on Equity (ROE)
-1.81%▼
Debt to Equity Ratio
42.87%▲
Quick Ratio
-0.04%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo